These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7592779

  • 1. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells.
    Grugel S, Finkenzeller G, Weindel K, Barleon B, Marmé D.
    J Biol Chem; 1995 Oct 27; 270(43):25915-9. PubMed ID: 7592779
    [Abstract] [Full Text] [Related]

  • 2. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells.
    Okajima E, Thorgeirsson UP.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):108-11. PubMed ID: 10733912
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 4. Lovastatin and tumor necrosis factor-alpha exhibit potentiated antitumor effects against Ha-ras-transformed murine tumor via inhibition of tumor-induced angiogenesis.
    Feleszko W, Bałkowiec EZ, Sieberth E, Marczak M, Dabrowska A, Giermasz A, Czajka A, Jakóbisiak M.
    Int J Cancer; 1999 May 17; 81(4):560-7. PubMed ID: 10225445
    [Abstract] [Full Text] [Related]

  • 5. Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants.
    Przybyszewska M, Miłoszewska J, Janik P.
    Cancer Lett; 1998 Sep 25; 131(2):157-61. PubMed ID: 9851248
    [Abstract] [Full Text] [Related]

  • 6. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression.
    Finkenzeller G, Sparacio A, Technau A, Marmé D, Siemeister G.
    Oncogene; 1997 Aug 07; 15(6):669-76. PubMed ID: 9264407
    [Abstract] [Full Text] [Related]

  • 7. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression.
    Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ.
    Cancer Res; 1996 Aug 01; 56(15):3436-40. PubMed ID: 8758908
    [Abstract] [Full Text] [Related]

  • 8. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W, Heidecker G, Troppmair J, Yanagihara K, Bassin RH, Rapp UR.
    Oncogene; 1993 Feb 01; 8(2):361-70. PubMed ID: 8426742
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells.
    Kieser A, Seitz T, Adler HS, Coffer P, Kremmer E, Crespo P, Gutkind JS, Henderson DW, Mushinski JF, Kolch W, Mischak H.
    Genes Dev; 1996 Jun 15; 10(12):1455-66. PubMed ID: 8666230
    [Abstract] [Full Text] [Related]

  • 10. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.
    Brogi E, Wu T, Namiki A, Isner JM.
    Circulation; 1994 Aug 15; 90(2):649-52. PubMed ID: 8044933
    [Abstract] [Full Text] [Related]

  • 11. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.
    Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J, Mansour SJ, Ahn NG, Kerbel RS.
    Cancer Res; 2000 Jan 15; 60(2):490-8. PubMed ID: 10667605
    [Abstract] [Full Text] [Related]

  • 12. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts.
    Milanini J, Viñals F, Pouysségur J, Pagès G.
    J Biol Chem; 1998 Jul 17; 273(29):18165-72. PubMed ID: 9660776
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29.
    Skopinska-Rózewska E, Janik P, Przybyszewska M, Sommer E, Bialas-Chromiec B.
    Int J Mol Med; 1998 Dec 17; 2(6):649-52. PubMed ID: 9850731
    [Abstract] [Full Text] [Related]

  • 14. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S, Fidder H, Neufeld G, Klagsbrun M.
    J Biol Chem; 1996 Mar 08; 271(10):5761-7. PubMed ID: 8621443
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways.
    Claffey KP, Wilkison WO, Spiegelman BM.
    J Biol Chem; 1992 Aug 15; 267(23):16317-22. PubMed ID: 1644816
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells.
    Dulak J, Józkowicz A, Ratajska A, Szuba A, Cooke JP, Dembińska-Kieć A.
    Vasc Med; 2000 Aug 15; 5(1):33-40. PubMed ID: 10737154
    [Abstract] [Full Text] [Related]

  • 17. Phorbol ester and bryostatin differentially regulate the hydrolysis of phosphatidylethanolamine in Ha-ras- and raf-oncogene-transformed NIH 3T3 cells.
    Kiss Z, Rapp UR, Pettit GR, Anderson WB.
    Biochem J; 1991 Jun 01; 276 ( Pt 2)(Pt 2):505-9. PubMed ID: 2049075
    [Abstract] [Full Text] [Related]

  • 18. Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP.
    Ghiso N, Rohan RM, Amano S, Garland R, Adamis AP.
    Invest Ophthalmol Vis Sci; 1999 May 01; 40(6):1033-9. PubMed ID: 10235536
    [Abstract] [Full Text] [Related]

  • 19. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.
    Kieser A, Weich HA, Brandner G, Marmé D, Kolch W.
    Oncogene; 1994 Mar 01; 9(3):963-9. PubMed ID: 8108142
    [Abstract] [Full Text] [Related]

  • 20. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity.
    Peretz D, Gitay-Goren H, Safran M, Kimmel N, Gospodarowicz D, Neufeld G.
    Biochem Biophys Res Commun; 1992 Feb 14; 182(3):1340-7. PubMed ID: 1540178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.